Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Drug and Alcohol Review|March 28, 2008
Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO StudyAline Inglez-Dias, Judith A Hahn, Paula J Lum, et al.
IRB|November 3, 2018
The Need to Track Payment Incentives to Participate in HIV ResearchBrandon Brown, Jerome T Galea, Karine Dubé, et al.
Substance Use & Misuse|August 8, 2019
"Another Person Was Going to Do It": The Provision of Injection Drug Use Initiation Assistance in a High-Risk U.S.-Mexico Border RegionMaria L Mittal, Andrew Guise, Claudia Rafful, et al.
The International Journal on Drug Policy|March 11, 2018
A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USAAndy Guise, Jason Melo, Maria Luisa Mittal, et al.
Harm Reduction Journal|September 16, 2016
A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER studyDaniel Werb, Richard Garfein, Thomas Kerr, et al.
The Science of the Total Environment|March 18, 2026
Comparing the fate of agricultural sulfur in two winegrowing regions using paired sulfur stable isotope and microbial community analysisLaura T Rea, Nicholas B Dragone, Matt Oliver, et al.
The International Journal on Drug Policy|August 9, 2015
Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CASaira S Siddiqui, Richard F Armenta, Jennifer L Evans, et al.
BMJ Open|February 19, 2017
Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studiesKerry N L Avery, Paula R Williamson, Carrol Gamble, et al.
Clinical Trials (London, England)|November 26, 2009
A cost-effectiveness analysis of subject recruitment strategies in the HIPAA era: results from a colorectal cancer screening adherence trialPaul C Schroy, Julie T Glick, Patricia Robinson, et al.
Asia-Pacific Journal of Clinical Oncology|April 20, 2010
Evaluation of the safety, pharmacokinetics and treatment effects of an alpha(nu)beta(3) integrin inhibitor on bone turnover and disease activity in men with hormone-refractory prostate cancer and bone metastasesMark A Rosenthal, Peter Davidson, Frederic Rolland, et al.
Pageof 10